Market Access News | pharmaphorum

News

Medicare plans accuse Teva of covering copays for patients

A class action suit has been filed in the US against Teva, claiming that the company illegally subsidised the copays for patients prescribed its multiple sclerosis therapy Copaxone to boost

News

J&J's Rybrevant okay challenges Tagrisso in first-line NSCLC

AstraZeneca's EGFR inhibitor Tagrisso has become the go-to therapy for EGFR-mutated non-small cell lung cancer (NSCLC), but now has competition from Johnson & Johnson's Rybrevant and La

News

Expert says supplies of mpox vaccine unlikely to suffice

Emergent BioSolutions, one of only three companies with a vaccine for mpox, has agreed to donate 50,000 doses of its shot for use in the current outbreak concentrated in central Africa, but

News

NGOs plead for Gaza ceasefire for polio vaccinations

The UN, WHO, and UNICEF have all called for a "polio pause" to the hostilities in the Gaza Strip to allow hundreds of thousands of children to be vaccinated against the virus.

News

Kamala Harris vows to extend key health reforms to all in US

Vice President Kamala Harris unveiled her economic agenda at a rally on Friday, with a pledge to widen healthcare reforms introduced by President Joe Biden, including Medicare negotiations

News

EU starts review of Enhertu in HER2-ultra-low breast cancer

The EMA has started a review of AstraZeneca and Daiichi Sankyo's antibody-drug conjugate (ADC) that could see the drug being used in advanced breast cancer with even lower levels of the HER

Medicare plans accuse Teva of covering copays for patients

J&J's Rybrevant okay challenges Tagrisso in first-line NSCLC

Expert says supplies of mpox vaccine unlikely to suffice

NGOs plead for Gaza ceasefire for polio vaccinations

Kamala Harris vows to extend key health reforms to all in US

EU starts review of Enhertu in HER2-ultra-low breast cancer

FDA kicks off review of Takeda's narcolepsy hopeful

How to meet your physicians where they are online

News

Editor's Picks